Global Nuclear Medicine Radioisotopes Market Report – Growth, Trends, and Forecast (2019 – 2024) | 360 Market Updates

Nuclear Medicine Radioisotopes

Report Title: “Nuclear Medicine Radioisotopes Market – Growth, Trends, and Forecast (2019 – 2024)“

Nuclear Medicine Radioisotopes Market Report (2019 – 2024) Provides the Leading Manufactures of Nuclear Medicine Radioisotopes market, market overview, scope of the market and Reasons to purchase this report. Also Report provides a 360-degree overview of the global Nuclear Medicine Radioisotopes market with special emphasis on all aspects including drivers, restraints, and opportunities, market and regional segmentation.

Get Sample PDF Of Report –

Nuclear Medicine Radioisotopes Market Report Covers Leading Manufacturers: Agfa,Gevaert Group , Cardiarc Ltd , Digirad Corporation , CMR Naviscan (Gamma Medica Inc.) , GE Healthcare , Positron Corp. , Segami Corporation , Siemens Healthcare GmBH , Nordion (Canada) Inc. , NTP Radioisotopes SOC Ltd , Bracco S.p.A , Cardinal Health Inc. , Curium

The Nuclear Medicine Radioisotopes Market Overview:

Increasing cases of cancer and cardiac ailments are the major drivers for the nuclear medicines radioisotopes market. Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics. They meet the statutory definition of drugs under Section 1861(t) of the Social Security Act because they either are included in the various drug compendia or recognized by hospital medical staff as drugs. Historically, nuclear medicine has been well established as a therapeutic modality for thyroid cancer, Graves’ disease, hyperthyroidism, and bone pain palliation, associated with skeletal metastasis. Hence, the broadening applications of radioisotopes are expected to propel market growth.

Inquire for further detailed information about Nuclear Medicine Radioisotopes Market Report –

Oncology Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Radiotherapy can be used to treat various medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. PET, which is a precise technique, uses isotopes produced in a cyclotron. It is highly used for a clinical role in oncology, with fluorine-18 as the tracer, and is proven to be the most accurate non-invasive method of detecting and evaluating most cancers. A new field for cancer treatment is targeted alpha therapy (TAT) or alpha radio-immunotherapy, especially for the control of dispersed cancers. Nuclear medicine is proven effective in oncology in several roles, spanning the course of the disease, including the characterization of a mass, staging, restaging, and monitoring of therapeutic response. Hence, owing to these associated factors, the oncology segment is expected to exhibit the fastest growth rate.

North America captured the Largest Market Share and is Expected to Retain its Dominance

North America captured the largest market share in the nuclear medicine radioisotopes market. The United States was the largest contributor to the revenue of North America, and is expected to retain its dominance owing to the higher procedural volume and increasing adoption of the nuclear medicine isotopes for various therapeutic applications. Bone scintigraphy is the next most common nuclear medicine procedure performed in the United States, but it represents only 17% of procedures. The volume of PET procedures in the United States is approximately 1.5 million per year. Oncology accounts for more than 90% of the PET and PET/CT procedures performed, whereas cardiology and neurology account for about 4% each. Canada is the largest producer of Technetium-99m. Due to the use of Tc-99m in radiopharmaceuticals, the market is expected to grow at a tremendous rate in Canada. 80% of the nuclear medicine market is driven by Tc-99m in various diagnostic procedures and treatments. Considering these factors associated with the United States and Canada, the North American market is expected to experience accelerated growth rates and market dominance.

The Scope of Nuclear Medicine Radioisotopes Market:

As per the , medical radioisotopes are defined as safe radioactive substances that are primarily used in the diagnosis of medical conditions. These radioisotopes, used in a diagnosis, emit gamma rays of energy that are sufficient to escape from the body. The rays also have a short half-life, which is apt, since the rays can decay as soon as the imaging is completed.

Order Full Copy of Report –

Reasons to Purchase this Report:

  • Current and future of Global Smart Cities Market outlook in the developed and emerging markets
    • Analysing various perspectives of the market with the help of Porter’s five forces analysis
    • Report customization as per the client’s requirements
    • Regions that are expected to witness fastest growth during the forecast period
    • Identifying the latest developments, market shares and strategies employed by the major market players
    • 3 month analyst support, along with the Market Estimate sheet (in Excel)

About 360 Market Updates:

360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:

Name: Mr. Ajay More

Email: [email protected]

Organization: 360 Market Updates

Phone: +14242530807/+44 203 239 8187

Tagged:- Google News, Nuclear Medicine Radioisotopes Market, Nuclear Medicine Radioisotopes Europe Market, Nuclear Medicine Radioisotopes APAC Market, Nuclear Medicine Radioisotopes Market By Application, Nuclear Medicine Radioisotopes Market By Rising Trends, Nuclear Medicine Radioisotopes Market Development, Nuclear Medicine Radioisotopes Market Forecast, Nuclear Medicine Radioisotopes Market Future, Nuclear Medicine Radioisotopes Market Growth, Nuclear Medicine Radioisotopes Market In Key Countries, Nuclear Medicine Radioisotopes Market Latest Report, Nuclear Medicine Radioisotopes Market Swot Analysis, Nuclear Medicine Radioisotopes Market Top Manufacturers, Nuclear Medicine Radioisotopes Sales Market, Nuclear Medicine Radioisotopes United States Market